17 Feb 2022

University of Chicago

Cancer Biology, PhD (F22)

Accepted via E-mail on 17 Feb 2022

Note

No GRE, 1 publication as a second/third author in IF 9 journal (published after submitted application), pre-print, 3-4 manuscripts in review, a couple of conference presentations (including AACR), good LORs

---